UNH
NEW YORK STOCK EXCHANGE, INC. · Health Care
UnitedHealth Group Inc
$401.74
+2.68 (+0.67%)
UNH News30 articles
XLV Retreats from Record as Mid-Sized Health Care Names Lag
XLV hit a record $169.71 before closing lower, lagging the S&P 500 by 0.74 points. Weakness among smaller health care holdings offset gains in top components.
UnitedHealth's Optum Health Beats 2026 Profit Goal, Investors Eye 2027 Growth
Optum Health reported $2.486B in adjusted operating earnings for H1 2026, beating its full-year minimum target by 12%, but investors look to 2027 for sustained growth.
Dow's Price-Weighted Drop: Six Stocks Drive 454-Point Slide
The Dow dropped 454 points, with six stocks accounting for 81% of the decline due to price-based weighting. Other indices fell modestly.
Dow Drops 370 Points as Five Stocks Drive Most of the Decline
The Dow Jones Industrial Average fell 370 points, with five stocks accounting for 59% of the decline. Broader markets showed resilience, suggesting sector rotation.
CVS Raises Guidance as Aetna Powers Q2 Beat
CVS Health raised its 2026 EPS outlook after a strong Q2, with Aetna contributing nearly all of the operating-profit increase. The stock rose in premarket trading.
Dow Crosses 54,000 Milestone as Caterpillar and Goldman Lead Charge
The Dow Jones Industrial Average surpassed 54,000 for the first time, driven by strong gains in Caterpillar and Goldman Sachs, which together accounted for nearly 60% of the index's advance.
Medicare Part D Subsidy Phaseout Poses Enrollment Risks for Standalone Plans
Centene (CNC) is most exposed to Medicare Part D subsidy phaseout, with 90% of its drug plan members in standalone plans. The end of the $3.6B demo could trigger enrollment shifts.
Humana's Medicare Advantage Restructuring Overshadows Strong Q2 Results
Humana's Q2 earnings beat was overshadowed by a major Medicare Advantage restructuring that will affect 600,000 members by 2027, sending shares down 6.8%.
Medicare Part D Subsidy Phaseout Widens Insurer Pricing Gap
CMS plans to end temporary Part D assistance after 2026, with 2027 bids up 23.7%. Insurers like Centene face enrollment risk as pricing gaps widen.
Humana Stock Tumbles 8% Premarket Despite Strong Q2, 2026 Outlook Signals Sharp H2 Loss
Humana shares dropped 8% premarket despite Q2 earnings and revenue beats, as the 2026 adjusted EPS floor of $9 implies a second-half loss of $8.91 per share.
Dow Rises 537 Points on Earnings-Driven Rotation into Value Stocks
The Dow Jones Industrial Average jumped 537 points on Tuesday, led by strong earnings from defensive and industrial stocks, while the Nasdaq slipped.
Molina Healthcare Shares Tumble as First-Half EPS Covers 73.5% of 2026 Floor
Molina Healthcare shares fell 9.4% after hours despite an earnings beat, as first-half adjusted EPS of $3.86 covers 73.5% of the 2026 floor, leaving a $1.39 gap to the full-year floor.
Dow Rises 370 Points as Four Stocks Drive Rally
The Dow Jones Industrial Average rose 369.74 points to 52,209.00, powered by four stocks that contributed 126% of the gains, while the Nasdaq climbed 1.3% on semiconductor strength.
Brent Crude Dips Below $90 as Fuel Margins Surge, Inflation Worries Mount
Brent crude eased to $88.28 after hitting a one-month high, but soaring fuel margins and $4 gasoline pose a greater inflation threat as global refinery runs drop.
Chip Sector Slide Masks Broad Earnings Strength in S&P 500
S&P 500 fell 0.51% to 7,533.77 as chip stocks dropped 4.3%, offsetting earnings beats from 75% of components. UnitedHealth and Morgan Stanley reported strong results.
Dow Drops 183 Points as High-Priced Stocks Weigh on Index
The Dow slipped 183 points on July 16, led by a 604-point drag from Goldman Sachs and Caterpillar, while other stocks offset losses. Tech and chip stocks also declined.
S&P 500 Concentration Risk Exposed as Chip Rout Hits Markets
U.S. stocks ended lower Thursday, led by a sharp decline in semiconductor shares, underscoring concentration risk in the S&P 500.
Abbott Leads Healthcare Surge as Insurers Show Mixed Results
Abbott Laboratories surged 10.9% despite a modest earnings beat, while UnitedHealth rose 2.6% on a larger beat. The healthcare sector ETF XLV gained 2.2%.
Humana Stock Slides 3.6% as High Valuation Meets Earnings Reality Check
Humana shares dropped 3.6% on Thursday, giving back an initial 4.1% rise, as investors reassess the stock's premium valuation ahead of its July 29 earnings report.
Dow Up 109 Points as UnitedHealth Surge Offsets Tech Slide
The Dow rose 109 points by midday Thursday, lifted by a UnitedHealth earnings beat, while a tech slide dragged the S&P 500 and Nasdaq lower.
U.S. Stocks Show Mixed Results as Tech Sector Weakens
U.S. stocks opened mixed Thursday, with the S&P 500 down 0.12% as tech stocks lagged, while the Dow rose 0.21% and the Russell 2000 gained 0.43%, signaling a rotation out of semiconductors.
Nasdaq and Dow Diverge as Steady Data Tests Tech Valuations
U.S. stock futures fell Thursday as steady economic data widened the gap between the Nasdaq and Dow, with TSMC dropping 4.6% despite strong earnings and UnitedHealth rising 6.7%.
UnitedHealth and Elevance Health Q2 Beats: How Much Upside Made It Into Guidance?
UnitedHealth raised its 2026 EPS floor by $1.25 after a $1.48 beat, while Elevance added just $0.25 after a $1.24 beat, highlighting a key divergence in guidance quality.
FTSE 100 Slips Despite Strong UK GDP; Takeover Bids for Rotork, Gooch & Housego
FTSE 100 drops 52 points to 10,464 despite UK GDP rising 0.8% in three months. Rotork, Gooch & Housego, and Ramsdens agree to takeover bids.
Narrow Tech Selloff Masks Broad Market Resilience as Rotation Plays Out
While the Nasdaq fell 0.9% on a memory-chip selloff, the equal-weight S&P 500 rose 0.18%, indicating the selling is narrow and a rotation into energy and defensive stocks is underway.
UnitedHealth Stock at $429: Earnings Test Looms as Investors Eye $25 EPS Target
UnitedHealth stock trades up ahead of Q2 earnings, with the market pricing in a long-term EPS target of $25 by 2028. Analysts watch for margin improvements and Optum recovery.
Bank Earnings, TSMC, and Netflix to Test Market's Profit Outlook
This week's earnings from major banks, TSMC, and Netflix will test whether profit growth can broaden beyond tech and energy without exposing credit weakness.
Healthcare Earnings Test: J&J, UnitedHealth, Abbott in Focus After Sector's 9% Drop
Major healthcare stocks report this week as the sector's 9% earnings decline goes under the microscope. J&J, UnitedHealth, and Abbott are key to determining if the drop is real or just a one-off.
Dow Gains 150 Points, But Two Stocks Drive 85% of Move
The Dow Jones Industrial Average gained 149.68 points on Friday, but Caterpillar and Nvidia drove about 85% of the move, highlighting concentrated market leadership.
Dow Jones Rebounds 340 Points as Caterpillar and Nvidia Lead Recovery
The Dow Jones rebounded 119 points after a 221-point drop, driven by Caterpillar and Nvidia. The price-weighted nature of the index amplified their impact.